Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
β1 Integrin regulates adult lung alveolar epithelial cell inflammation
Erin J. Plosa, John T. Benjamin, Jennifer M. Sucre, Peter M. Gulleman, Linda A. Gleaves, Wei Han, Seunghyi Kook, Vasiliy V. Polosukhin, Scott M. Haake, Susan H. Guttentag, Lisa R. Young, Ambra Pozzi, Timothy S. Blackwell, Roy Zent
Erin J. Plosa, John T. Benjamin, Jennifer M. Sucre, Peter M. Gulleman, Linda A. Gleaves, Wei Han, Seunghyi Kook, Vasiliy V. Polosukhin, Scott M. Haake, Susan H. Guttentag, Lisa R. Young, Ambra Pozzi, Timothy S. Blackwell, Roy Zent
View: Text | PDF
Research Article Inflammation Pulmonology

β1 Integrin regulates adult lung alveolar epithelial cell inflammation

  • Text
  • PDF
Abstract

Integrins, the extracellular matrix receptors that facilitate cell adhesion and migration, are necessary for organ morphogenesis; however, their role in maintaining adult tissue homeostasis is poorly understood. To define the functional importance of β1 integrin in adult mouse lung, we deleted it after completion of development in type 2 alveolar epithelial cells (AECs). Aged β1 integrin–deficient mice exhibited chronic obstructive pulmonary disease–like (COPD-like) pathology characterized by emphysema, lymphoid aggregates, and increased macrophage infiltration. These histopathological abnormalities were preceded by β1 integrin–deficient AEC dysfunction such as excessive ROS production and upregulation of NF-κB–dependent chemokines, including CCL2. Genetic deletion of the CCL2 receptor, Ccr2, in mice with β1 integrin–deficient type 2 AECs impaired recruitment of monocyte-derived macrophages and resulted in accelerated inflammation and severe premature emphysematous destruction. The lungs exhibited reduced AEC efferocytosis and excessive numbers of inflamed type 2 AECs, demonstrating the requirement for recruited monocytes/macrophages in limiting lung injury and remodeling in the setting of a chronically inflamed epithelium. These studies support a critical role for β1 integrin in alveolar homeostasis in the adult lung.

Authors

Erin J. Plosa, John T. Benjamin, Jennifer M. Sucre, Peter M. Gulleman, Linda A. Gleaves, Wei Han, Seunghyi Kook, Vasiliy V. Polosukhin, Scott M. Haake, Susan H. Guttentag, Lisa R. Young, Ambra Pozzi, Timothy S. Blackwell, Roy Zent

×

Figure 9

β1-Deficient AECs generate excess inflammatory mediators via ROS production.

Options: View larger image (or click on image) Download as PowerPoint
β1-Deficient AECs generate excess inflammatory mediators via ROS product...
(A and B) Primary β1rtTA type 2 AECs produce increased superoxide and H2O2 by LumiMax assay (A; n = 7 mice/group) and Amplex Red assay (B; n = 5 β1f/f, n = 7 β1rtTA mice), respectively. (C) No difference in mitochondrial ROS production in β1f/f and β1rtTA type 2 AECs by MitoSOX assay. n = 8–9 mice/group. ex, excitation; em, emission. (D) Increased gene expression of Duox1 in primary type 2 AECs isolated from β1rtTA mice. n = 6 mice/group. (E) TEMPOL treatment decreases CCL2 secretion by primary type 2 AECs isolated from β1rtTA mice. 2 mM; n = 4 mice/group). (F) DPI treatment decreases CCL2 secretion by primary type 2 AECs isolated from β1rtTA mice. 10 μM; n = 7 β1f/f, n = 8 β1rtTA mice. (G) CCL2 secretion is not different between β1f/f and β1rtTA type 2 AECs after treatment with the NOX1/4 inhibitor GKT137831. 10 μM; n = 5 β1f/f, n = 5 β1rtTA mice. (H) Macrophage migration in response to β1rtTA type 2 AEC media is decreased by treatment with CCL2-neutralizing antibody (NAb) and DPI. n = 4–8 mice/group. *P < 0.05 by 2-tailed Student’s t test. CCR2, recombinant CCR2.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts